Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 74
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
Tithi Roy, Samuel Boateng, Mohammad B. Uddin, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1671-1671
Open Access | Times Cited: 44
Reconstruction of the cell pseudo-space from single-cell RNA sequencing data with scSpace
Jingyang Qian, Jie Liao, Ziqi Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation
Tithi Roy, Sergette Banang‐Mbeumi, Samuel Boateng, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 24
Structure–Photoreactivity Relationship Study of Substituted 3-Hydroxyflavones and 3-Hydroxyflavothiones for Improving Carbon Monoxide Photorelease
Yann Anton Jézéquel, Filip Svěrák, Andrea Ramundo, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 7, pp. 4888-4903
Open Access | Times Cited: 7
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors
Shelly Pathania, Olli T. Pentikäinen, Pankaj Kumar Singh
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188631-188631
Open Access | Times Cited: 53
Cancer chemopreventive role of fisetin: Regulation of cell signaling pathways in different cancers
Ammad Ahmad Farooqi, Humaira Naureen, Rabbia Zahid, et al.
Pharmacological Research (2021) Vol. 172, pp. 105784-105784
Closed Access | Times Cited: 40
Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead
Sukriti Vishwas, Sachin Kumar Singh, Monica Gulati, et al.
Chemico-Biological Interactions (2022) Vol. 356, pp. 109869-109869
Closed Access | Times Cited: 31
A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme
PRIYANKA SOLANKI, Nisarg Rana, Prakash C. Jha, et al.
Biocell (2023) Vol. 47, Iss. 4, pp. 707-729
Open Access | Times Cited: 15
Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties
Aladdin M. Srour, Siva S. Panda, Ahmed Mostafa, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105466-105466
Open Access | Times Cited: 27
Comparative toxicity assessment of fisetin-aided artificial intelligence-assisted drug design targeting epibulbar dermoid through phytochemicals
Muhammad Naveed, Amina Abid, Tariq Aziz, et al.
Open Chemistry (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Fisetin is a selective adenosine triphosphate‐competitive inhibitor for mitogen‐activated protein kinase kinase 4 to inhibit lipopolysaccharide‐stimulated inflammation
Ziyu He, Takuhiro Uto, Shunsuke Tanigawa, et al.
BioFactors (2024)
Open Access | Times Cited: 3
Synthesis, in silico modelling, and in vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents
Samuel Boateng, Tithi Roy, Kara Torrey, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 9
A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023
Reshma Susan Ipe, Sunil Kumar, Feba Benny, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 7
Antioxidant capacity and cytotoxic effect of an optimized extract of isabella grape (Vitis labrusca) on breast cancer cells
M. Daniela Vélez, María Alejandra Llano-Ramírez, Carolina Ramón, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16540-e16540
Open Access | Times Cited: 6
Survey on computer-aided automated melanoma detection
Abhinandan Kumar Tiwari, Manoj Kumar Mishra, Amiya Ranjan Panda, et al.
Computer Methods in Biomechanics and Biomedical Engineering Imaging & Visualization (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 1
New Propargyloxy Derivatives of Galangin, Kaempferol and Fisetin—Synthesis, Spectroscopic Analysis and In Vitro Anticancer Activity on Head and Neck Cancer Cells
Robert Kubina, Kamil Krzykawski, Arkadiusz Sokal, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2288-2288
Open Access | Times Cited: 3
Binding interactions of hydrophobically-modified flavonols with β-glucosidase: fluorescence spectroscopy and molecular modelling study
Л. В. Чепелева, Oleksii O. Demidov, Arsenii D. Snizhko, et al.
RSC Advances (2023) Vol. 13, Iss. 48, pp. 34107-34121
Open Access | Times Cited: 2
Standardized Pomegranate (Pomella®) and Red Maple (Maplifa®) Extracts and Their Phenolics Protect Type I Collagen by the Inhibition of Matrix Metalloproteinases, Collagenase, and Collagen Cross-Linking
Huifang Li, Tithi Roy, Samuel Boateng, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7919-7919
Open Access | Times Cited: 4
Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation
Tithi Roy, Samuel Boateng, Sergette Banang‐Mbeumi, et al.
Data in Brief (2021) Vol. 35, pp. 106858-106858
Open Access | Times Cited: 5
Natural Modulators of Key Signaling Pathways in Skin Inflammageing
Qianqian Ren, Liping Qu, Ye Yuan, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2967-2988
Open Access
Identification of novel c -Kit inhibitors from natural sources using virtual screening and molecular dynamics simulations
Abdelbaset Mohamed Elasbali, Waleed Abu Al‐Soud, Elyasa Mustafa Elfaki, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5982-5994
Closed Access | Times Cited: 1
Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing
Samuel Boateng, Tithi Roy, Mercy E. Agbo, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 1
Identification of potential inhibitors of cutaneous Melanoma and Non-Melanoma skin cancer cells through in-vitro and in-silico screening of a small library of Phenolic compounds
Samuel Boateng, Tithi Roy, Mercy E. Agbo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Synthesis and characterization of novel mono, bis and tris heteroaryl chalcone derivatives of 1,3,5-trimethoxybenzene
M. Fatih Polat, Derya Aktaş Anı
Organic Communications (2021) Vol. 14, Iss. 1, pp. 39-47
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top